GRIN Therapeutics Receives PRIME Designation from EMA for Radiprodil
01 Apr 2025 //
PR NEWSWIRE
GRIN Therapeutics gets FDA Orphan Drug Designation for Radiprodil
17 Mar 2025 //
PR NEWSWIRE
GRIN Therapeutics gets FDA Breakthrough Therapy for Radiprodil
25 Feb 2025 //
PR NEWSWIRE
GRIN Therapeutics Presents Honeycomb Trial Data of Radiprodil
09 Dec 2024 //
PR NEWSWIRE
GRIN Therapeutics to Present Honeycomb Trial Data on Radiprodil
21 Nov 2024 //
PR NEWSWIRE
GRIN Announces Initiation Of Astroscape Trial t of Tuberous Sclerosis
08 Oct 2024 //
PR NEWSWIRE